# Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)

> **NCT00163397** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 120 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide

## Key facts

- **NCT ID:** NCT00163397
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 120 (—)
- **Last updated:** 2016-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163397, "Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00163397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*